Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity

Medicine and Dentistry

• Acetylcholinesterase 33%
• Acetylcholinesterase Inhibitor 33%
• Acute Toxicity 33%
• Calcium Transport 33%
• Central Nervous System 33%
• Endocannabinoid 33%
• Endocannabinoid System 33%
• Epileptic Seizure 66%
• Excitatory Postsynaptic Potential 100%
• Hippocampus 33%
• Long-Term Depression 33%
• Muscarinic Acetylcholine Receptor 100%
• NMDA Receptor 33%
• Organophosphorus Compound 33%
• Paraoxon 33%
• Peripheral Nervous System 33%
• Receptor 33%
• Respiratory Failure 33%
• Soman 66%
• Sommer's Sector 33%
• Stratum Radiatum 33%
• Synapse 66%

Neuroscience

• Calcium Transport 33%
• Central Nervous System 33%
• Cholinergic Crisis 33%
• Excitatory Postsynaptic Potential 100%
• Hippocampus 33%
• Long-Term Depression 33%
• Muscarinic Acetylcholine Receptor M1 33%
• Muscarinic Acetylcholine Receptor M3 33%
• Neurotoxicity 33%
• NMDA Receptor 33%
• Paraoxon 33%
• Peripheral Nervous System 33%
• Presynaptic Mechanism 33%
• Receptor 33%
• Schaffer Collateral 33%
• Soman 66%
• Synapse 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Acetylcholinesterase 33%
• Acute Toxicity 33%
• Cholinergic Crisis 33%
• Cholinesterase Inhibitor 33%
• Endocannabinoid 33%
• Endocannabinoid System 33%
• Muscarinic Receptor 100%
• N Methyl Dextro Aspartic Acid Receptor 33%
• Neurotoxicity 33%
• Organophosphorus Compound 33%
• Paralysis 33%
• Receptor 33%
• Respiratory Failure 33%